FDA Authorizes New Drug for Early Stages of Alzheimer’s Disease
A controversy has accompanied the whole route to approval and now beyond, but today the FDA authorized use of a new drug, Aduhelm, for early stages of Alzheimer’s disease. Here is what the LA Alzheimer’s President & CEO, Heather Cooper Ortner, to say about it: “Today, the FDA approved









